 Coronary patency infarct size ventricular function thrombolytic therapy acute myocardial infarction results tissue plasminogen activator Toronto TPAT placebo-controlled trial TPAT Study Group Infarct size ventricular function infarct-related coronary artery patency patients part placebo-controlled trial recombinant tissue-type plasminogen activator rt-PA acute myocardial infarction Coronary angiography initiation treatment patients group days patients group groups radionuclide ventriculography day treatment quantitative thallium scintigraphy day group infarct-related artery patent patients global regional thallium defect occluded artery Infarct regional ejection fraction early late studies infarct-related artery patent changes global noninfarct regional ejection fraction similar irrespective perfusion status Infarct regional ejection fraction fixed thallium defect infarct-related artery group day patency infarct-related artery difference patency treatment assignment left ventricular function infarct size patients infarct-related artery patency evidence effect rt-PA therapy coronary patency group group